Dennis N. Phung

Dennis N. Phung has extensive experience in the field of Quality Assurance and Compliance in the biopharmaceutical industry. Dennis N. currently serves as the Director of Quality at Ansun Biopharma, Inc., overseeing all quality efforts and compliance functions. In this role, they manage the review of testing data and records, provides support for the vendor qualification program, and conducts quality audits and risk assessments of third-party vendors.

Prior to their current position, Dennis held the role of Director of Quality Assurance at Epirium Bio, where they provided quality support for all CMC activities. Before that, they worked at Senhwa Biosciences as the Associate Director of Quality & Compliance, where they implemented a new quality system and directed the QA functions in CMC and quality activities. Dennis N. also collaborated on the review and approval of third-party method validation protocols, reports, and master batch records.

Earlier in their career, Dennis held positions at Teva Pharmaceuticals, Amylin Pharmaceuticals, Pfizer Pharmaceuticals Inc., and Centocor Inc. In these roles, they gained experience in managing analytical data reviews and approvals, stability programs, method transfers, and coordinating stability studies with external laboratories.

Overall, Dennis N. Phung has amassed significant expertise in quality assurance, compliance, and laboratory operations throughout their career in the biopharmaceutical industry.

Dennis N. Phung holds a Bachelor of Science degree in Analytical Chemistry from Temple University. Their educational background also includes a Certification of Training in USP Dissolution Training from USP Pharmacopeia Convention Inc. Additionally, they received a Certification of Deviation and CAPA from TEVA Pharmaceutical Corporate Technical Training, specializing in Investigation, Deviation, and CAPA. The specific years of enrollment and completion for each educational experience were not provided.